OrSight Pharma Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

OrSight Pharma General Information

Description

Developer of a novel small molecule therapy and VEGF-independent anti-angiogenic agent intended for neovascular age-related macular degeneration and chronic retinal disease treatment. The company utilizes a first-in-class MetAP2 inhibitor that suppresses abnormal blood vessel growth and reduces retinal edema through a distinct biological pathway, enabling ophthalmologists and retina specialists to achieve durable visual outcomes for patients who show insufficient response to current standard-of-care injectable biologics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 13 Wadi El-Haj Street
  • Nazareth
  • Israel
Primary Industry
Pharmaceuticals
Other Industries
Other Healthcare Services
Biotechnology
Vertical(s)
Corporate Office
  • 13 Wadi El-Haj Street
  • Nazareth
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OrSight Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Generating Revenue
1. Seed Round 01-Jan-2023 Completed Generating Revenue
To view OrSight Pharma’s complete valuation and funding history, request access »

OrSight Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OrSight Pharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arieli Group Venture Capital Minority
Hadasit Venture Capital Minority
NGT HealthCare II Venture Capital Minority
Yissum Accelerator/Incubator
To view OrSight Pharma’s complete investors history, request access »

OrSight Pharma FAQs

  • When was OrSight Pharma founded?

    OrSight Pharma was founded in 2023.

  • Where is OrSight Pharma headquartered?

    OrSight Pharma is headquartered in Nazareth, Israel.

  • What is the size of OrSight Pharma?

    OrSight Pharma has 2 total employees.

  • What industry is OrSight Pharma in?

    OrSight Pharma’s primary industry is Pharmaceuticals.

  • Is OrSight Pharma a private or public company?

    OrSight Pharma is a Private company.

  • What is OrSight Pharma’s current revenue?

    The current revenue for OrSight Pharma is .

  • Who are OrSight Pharma’s investors?

    Arieli Group, Hadasit, NGT HealthCare II, and Yissum have invested in OrSight Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process